Replies to post #362524 on Amarin Corp Plc (AMRN)

[ggwpq]

Ns, your link shows three more faint lines in addition to the bolded headline. Look at it again.

[marjac]

On Law360, the headline is "Full Fed. Circ. Told Teva Overreacting In Skinny Label IP Case". The article is reporting on GSK's Brief filed on Monday, opposing En Banc review. According to the article, GSK's Brief says that Teva's concern that the decision will have a "seismic" impact on the drug industry, is "overblown".